← Back to Search

Virus Therapy

Flocked swab paired with Roche Cobas 4800 for Cervical Cancer (ACCESS Trial)

N/A
Waitlist Available
Led By Darcy Rao, PhD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during study year 1
Awards & highlights
No Placebo-Only Group

Summary

This trial is evaluating whether self-collection of vaginal samples for HPV testing is an effective alternative cervical cancer screening strategy for persons with HIV and/or limited access to care.

Eligible Conditions
  • Cervical Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during study year 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and during study year 1 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Confidence with self-collection
Ease of returning home kits
Proportion of eligible individuals who accept self-sampling kits
+3 more
Secondary study objectives
Attitudes and preferences for screening
Colposcopy results checklist
HPV prevalence checklist
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: HPV self-samplingExperimental Treatment1 Intervention
Participants will be offered self-collection kits for HPV-based cervical cancer screening.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,812 Previous Clinical Trials
1,913,737 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
359 Previous Clinical Trials
411,208 Total Patients Enrolled
Darcy Rao, PhD, MPHPrincipal InvestigatorUniversity of Washington
~16 spots leftby Nov 2025